{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:59:27Z","timestamp":1781632767296,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01282467"],"award-info":[{"award-number":["R01282467"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2110396"],"award-info":[{"award-number":["W81XWH2110396"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Helis Foundation"},{"DOI":"10.13039\/100020187","name":"Macy Easom Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020187","id-type":"DOI","asserted-by":"publisher"}]},{"name":"William M. and Ann K. Grace Charitable Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatoblastoma (HB) is the most common pediatric liver malignancy. However, its cellular origin and molecular drivers remain poorly defined. Using single-nuclear RNA sequencing (snRNA-seq), we identified a proliferative, hepatocyte-derived tumor cell population (cycling Hep\n                    <jats:sub>T<\/jats:sub>\n                    ) enriched for Enhancer of Zeste Homolog 2 (\n                    <jats:italic>EZH2)<\/jats:italic>\n                    expression, particularly in the aggressive embryonal subtype. Integrative genomic and transcriptomic profiling confirmed\n                    <jats:italic>EZH2<\/jats:italic>\n                    overexpression. Disruption of the PRC2 complex was evident through mislocalization and reduced expression of SUZ12, a core component.\n                    <jats:italic>EZH2<\/jats:italic>\n                    overexpression correlated with upregulation of mitotic regulators such as\n                    <jats:italic>AURKB<\/jats:italic>\n                    and\n                    <jats:italic>Ki67<\/jats:italic>\n                    in human HB gene expression analysis as compared to background liver. Targeted sequencing identified variants of uncertain significance in\n                    <jats:italic>EZH2<\/jats:italic>\n                    and\n                    <jats:italic>SUZ12<\/jats:italic>\n                    in 11 of 11 patient tumors. Pharmacologic inhibition of EZH2 with EPZ-6438 reduced proliferation and sensitized HB cells to cisplatin through gene regulation, potentially modulating platinum accumulation both in vitro and in vivo. In summary, EZH2 promotes HB progression through epigenetic silencing and noncanonical signaling pathways. These findings support EZH2\u2019s contribution to HB pathogenesis, therefore identifying it as a novel therapeutic target.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-38038-0","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:46:36Z","timestamp":1770360396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the oncogenic role of aberrant EZH2 in hepatoblastoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Kathryn","family":"Glaser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica A. K.","family":"DePasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Berklite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Hickner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Badachhape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somak","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Schepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai A.","family":"Timchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James I.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarangarajan","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Tiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Takebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Woodfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev A.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Bondoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"38038_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/children6010001","author":"IIP Lim","year":"2018","unstructured":"Lim, I. I. P., Bondoc, A. J., Geller, J. I. & Tiao, G. M. Hepatoblastoma-the evolution of Biology, surgery, and transplantation. Children (Basel, Switzerland) https:\/\/doi.org\/10.3390\/children6010001 (2018).","journal-title":"Children (Basel, Switzerland)"},{"key":"38038_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jpedsurg.2022.05.022","volume":"57","author":"SA Vasudevan","year":"2022","unstructured":"Vasudevan, S. A. et al. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from children\u2019s oncology group trial, AHEP0731. J. Pediatr. Surg. 57, 251\u2013256. https:\/\/doi.org\/10.1016\/j.jpedsurg.2022.05.022 (2022).","journal-title":"J. Pediatr. Surg."},{"key":"38038_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12262-023-03839-4","volume":"86","author":"Y Lai","year":"2024","unstructured":"Lai, Y., Wu, D., Deng, R., Li, J. & Yang, J. Liver transplantation in children with advanced hepatoblastoma: A systematic review and meta-analysis. Indian J. Surg. 86, 64\u201372 (2024).","journal-title":"Indian J. Surg."},{"key":"38038_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers, R. L. et al. Risk-stratified staging in paediatric hepatoblastoma: A unified analysis from the Children\u2019s Hepatic tumors International Collaboration. Lancet Oncol. 18, 122\u2013131. https:\/\/doi.org\/10.1016\/S1470-2045(16)30598-8 (2017).","journal-title":"Lancet Oncol."},{"key":"38038_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.hpb.2018.03.018","volume":"20","author":"S Nakagawa","year":"2018","unstructured":"Nakagawa, S. et al. Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma. HPB (Oxford) 20, 939\u2013948. https:\/\/doi.org\/10.1016\/j.hpb.2018.03.018 (2018).","journal-title":"HPB (Oxford)"},{"key":"38038_CR6","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.7150\/thno.41712","volume":"10","author":"Y Dang","year":"2020","unstructured":"Dang, Y. et al. Interleukin 1beta-mediated HOXC10 overexpression promotes hepatocellular carcinoma metastasis by upregulating PDPK1 and VASP. Theranostics 10, 3833\u20133848. https:\/\/doi.org\/10.7150\/thno.41712 (2020).","journal-title":"Theranostics"},{"key":"38038_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jb\/mvab007","volume":"170","author":"S Hanaki","year":"2021","unstructured":"Hanaki, S. & Shimada, M. Targeting EZH2 as cancer therapy. J. Biochem. 170, 1\u20134 (2021).","journal-title":"J. Biochem."},{"key":"38038_CR8","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.3892\/mmr.2017.8363","volume":"17","author":"D Zhang","year":"2018","unstructured":"Zhang, D. et al. EZH2 enhances the invasive capability of renal cell carcinoma cells via activation of STAT3. Mol. Med. Rep. 17, 3621\u20133626. https:\/\/doi.org\/10.3892\/mmr.2017.8363 (2018).","journal-title":"Mol. Med. Rep."},{"key":"38038_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40364-018-0122-2","volume":"6","author":"L Gan","year":"2018","unstructured":"Gan, L. et al. Epigenetic regulation of cancer progression by EZH2: From biological insights to therapeutic potential. Biomark Res. 6, 10. https:\/\/doi.org\/10.1186\/s40364-018-0122-2 (2018).","journal-title":"Biomark Res."},{"key":"38038_CR10","unstructured":"Noel, K. I., Raoof, R. M. Khamees, N. H. Cancer stem cells and their detection using specific cancer stem cell markers-a new strategy for cancer therapies. (2021)."},{"key":"38038_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12865-022-00502-7","volume":"23","author":"S-Y Wu","year":"2022","unstructured":"Wu, S.-Y. et al. The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma. BMC Immunol. 23, 28 (2022).","journal-title":"BMC Immunol."},{"key":"38038_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/cas.14840","volume":"112","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. The noncanonical role of EZH2 in cancer. Cancer Sci. 112, 1376\u20131382. https:\/\/doi.org\/10.1111\/cas.14840 (2021).","journal-title":"Cancer Sci."},{"key":"38038_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.741302","volume":"12","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. Easy or not-the advances of EZH2 in regulating T cell development, differentiation, and activation in antitumor immunity. Front. Immunol. 12, 741302. https:\/\/doi.org\/10.3389\/fimmu.2021.741302 (2021).","journal-title":"Front. Immunol."},{"key":"38038_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu, F. et al. Wnt\/beta-catenin signaling in cancers and targeted therapies. Signal Transduct. Target Ther. 6, 307. https:\/\/doi.org\/10.1038\/s41392-021-00701-5 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"38038_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Cancer epigenetics: From laboratory studies and clinical trials to precision medicine. Cell Death Discov. 10, 28. https:\/\/doi.org\/10.1038\/s41420-024-01803-z (2024).","journal-title":"Cell Death Discov."},{"key":"38038_CR16","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s42003-021-02562-8","volume":"4","author":"A Bondoc","year":"2021","unstructured":"Bondoc, A. et al. Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma. Commun. Biol. 4, 1049. https:\/\/doi.org\/10.1038\/s42003-021-02562-8 (2021).","journal-title":"Commun. Biol."},{"key":"38038_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan, R., Du, W. & Guo, W. EZH2: A novel target for cancer treatment. J. Hematol. Oncol. 13, 104. https:\/\/doi.org\/10.1186\/s13045-020-00937-8 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"38038_CR18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/17501911.2024.2410693","volume":"16","author":"I Fischetti","year":"2024","unstructured":"Fischetti, I., De Luca, M. & Jachetti, E. Exploring the role of EZH2 modulation in shaping the tumor microenvironment. Epigenomics 16, 1265\u20131268. https:\/\/doi.org\/10.1080\/17501911.2024.2410693 (2024).","journal-title":"Epigenomics"},{"key":"38038_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1055\/s-0040-1722645","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Molecular mechanisms of hepatoblastoma. Semin. Liver Dis. 41, 28\u201341. https:\/\/doi.org\/10.1055\/s-0040-1722645 (2021).","journal-title":"Semin. Liver Dis."},{"key":"38038_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2020.06.010","volume":"21","author":"J Zhao","year":"2021","unstructured":"Zhao, J., Qi, Y. F. & Yu, Y. R. STAT3: A key regulator in liver fibrosis. Ann. Hepatol. 21, 100224. https:\/\/doi.org\/10.1016\/j.aohep.2020.06.010 (2021).","journal-title":"Ann. Hepatol."},{"key":"38038_CR21","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.7150\/jca.50675","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y., Hu, Z., Li, J. & Hu, T. EZH2 exacerbates breast cancer by methylating and activating STAT3 directly. J. Cancer 12, 5220\u20135230. https:\/\/doi.org\/10.7150\/jca.50675 (2021).","journal-title":"J. Cancer"},{"key":"38038_CR22","doi-asserted-by":"publisher","first-page":"10007","DOI":"10.1038\/s41467-024-53802-4","volume":"15","author":"PV Wu","year":"2024","unstructured":"Wu, P. V. et al. A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma. Nat. Commun. 15, 10007. https:\/\/doi.org\/10.1038\/s41467-024-53802-4 (2024).","journal-title":"Nat. Commun."},{"key":"38038_CR23","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.1038\/s41467-024-52757-w","volume":"15","author":"TA Kluiver","year":"2024","unstructured":"Kluiver, T. A. et al. Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids. Nat. Commun. 15, 8576. https:\/\/doi.org\/10.1038\/s41467-024-52757-w (2024).","journal-title":"Nat. Commun."},{"key":"38038_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.904633","volume":"12","author":"Z Wen","year":"2022","unstructured":"Wen, Z. et al. Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development. Front. Oncol. 12, 904633. https:\/\/doi.org\/10.3389\/fonc.2022.904633 (2022).","journal-title":"Front. Oncol."},{"key":"38038_CR25","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jhep.2024.01.003","volume":"80","author":"AF Espinoza","year":"2024","unstructured":"Espinoza, A. F. et al. A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J. Hepatol. 80, 610\u2013621. https:\/\/doi.org\/10.1016\/j.jhep.2024.01.003 (2024).","journal-title":"J. Hepatol."},{"key":"38038_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/hep.28888","volume":"65","author":"P Sumazin","year":"2017","unstructured":"Sumazin, P. et al. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 65, 104\u2013121. https:\/\/doi.org\/10.1002\/hep.28888 (2017).","journal-title":"Hepatology"},{"key":"38038_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30774","volume":"71","author":"K Glaser","year":"2024","unstructured":"Glaser, K. et al. EZH2 is a key component of hepatoblastoma tumor cell growth. Pediatr. Blood Cancer 71, e30774. https:\/\/doi.org\/10.1002\/pbc.30774 (2024).","journal-title":"Pediatr. Blood Cancer"},{"key":"38038_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103986","volume":"29","author":"Q Bao","year":"2024","unstructured":"Bao, Q., Kumar, A., Wu, D. & Zhou, J. Targeting EED as a key PRC2 complex mediator toward novel epigenetic therapeutics. Drug Discov. Today 29, 103986 (2024).","journal-title":"Drug Discov. Today"},{"key":"38038_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12920-017-0271-4","volume":"10","author":"DT Cheng","year":"2017","unstructured":"Cheng, D. T. et al. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing. BMC Med. Genomics 10, 33. https:\/\/doi.org\/10.1186\/s12920-017-0271-4 (2017).","journal-title":"BMC Med. Genomics"},{"key":"38038_CR30","doi-asserted-by":"publisher","first-page":"10929","DOI":"10.1093\/nar\/gkac861","volume":"50","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. A cryptic transactivation domain of EZH2 binds AR and AR\u2019s splice variant, promoting oncogene activation and tumorous transformation. Nucleic Acids Res. 50, 10929\u201310946. https:\/\/doi.org\/10.1093\/nar\/gkac861 (2022).","journal-title":"Nucleic Acids Res."},{"key":"38038_CR31","doi-asserted-by":"publisher","first-page":"36719","DOI":"10.18632\/oncotarget.26429","volume":"9","author":"K Tatton-Brown","year":"2018","unstructured":"Tatton-Brown, K. et al. Correction: Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height. Oncotarget 9, 36719. https:\/\/doi.org\/10.18632\/oncotarget.26429 (2018).","journal-title":"Oncotarget"},{"key":"38038_CR32","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: An ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560 (2018).","journal-title":"Bioinformatics"},{"key":"38038_CR33","doi-asserted-by":"publisher","unstructured":"Misra, S., Li, H. Aluru, S. Efficient Architecture-Aware Acceleration of BWA-MEM for Multicore Systems. https:\/\/doi.org\/10.48550\/arXiv.1907.12931 (2019).","DOI":"10.48550\/arXiv.1907.12931"},{"key":"38038_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"38038_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience https:\/\/doi.org\/10.1093\/gigascience\/giab008 (2021).","journal-title":"Gigascience"},{"key":"38038_CR36","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: Fast processing of NGS alignment formats. Bioinformatics 31, 2032\u20132034. https:\/\/doi.org\/10.1093\/bioinformatics\/btv098 (2015).","journal-title":"Bioinformatics"},{"key":"38038_CR37","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/bioinformatics\/btz033","volume":"35","author":"LE Mose","year":"2019","unstructured":"Mose, L. E., Perou, C. M. & Parker, J. S. Improved indel detection in DNA and RNA via realignment with ABRA2. Bioinformatics 35, 2966\u20132973. https:\/\/doi.org\/10.1093\/bioinformatics\/btz033 (2019).","journal-title":"Bioinformatics"},{"key":"38038_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw227","volume":"44","author":"Z Lai","year":"2016","unstructured":"Lai, Z. et al. VarDict: A novel and versatile variant caller for next-generation sequencing in cancer research. Nucleic Acids Res. 44, e108. https:\/\/doi.org\/10.1093\/nar\/gkw227 (2016).","journal-title":"Nucleic Acids Res."},{"key":"38038_CR39","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jmoldx.2020.06.006","volume":"22","author":"HK Tsai","year":"2020","unstructured":"Tsai, H. K. et al. Targeted Informatics for optimal detection, characterization, and quantification of FLT3 internal tandem duplications across multiple next-generation sequencing platforms. J. Mol. Diagn. 22, 1162\u20131178. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.06.006 (2020).","journal-title":"J. Mol. Diagn."},{"key":"38038_CR40","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/humu.23615","volume":"39","author":"M Wang","year":"2018","unstructured":"Wang, M. et al. hgvs: A Python package for manipulating sequence variants using HGVS nomenclature: 2018 Update. Hum. Mutat. 39, 1803\u20131813. https:\/\/doi.org\/10.1002\/humu.23615 (2018).","journal-title":"Hum. Mutat."},{"key":"38038_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac931","volume":"51","author":"BS Pedersen","year":"2023","unstructured":"Pedersen, B. S. & de Ridder, J. Echtvar: compressed variant representation for rapid annotation and filtering of SNPs and indels. Nucleic Acids Res. 51, e3. https:\/\/doi.org\/10.1093\/nar\/gkac931 (2023).","journal-title":"Nucleic Acids Res."},{"key":"38038_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li, M. M. et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: A joint consensus recommendation of the association for molecular pathology, american society of clinical oncology, and college of American pathologists. J. Mol. Diagn. 19, 4\u201323. https:\/\/doi.org\/10.1016\/j.jmoldx.2016.10.002 (2017).","journal-title":"J. Mol. Diagn."},{"key":"38038_CR43","doi-asserted-by":"publisher","first-page":"14049","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049. https:\/\/doi.org\/10.1038\/ncomms14049 (2017).","journal-title":"Nat. Commun."},{"key":"38038_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giaa151","author":"MD Young","year":"2020","unstructured":"Young, M. D. & Behjati, S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. Gigascience https:\/\/doi.org\/10.1093\/gigascience\/giaa151 (2020).","journal-title":"Gigascience"},{"key":"38038_CR45","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296. https:\/\/doi.org\/10.1186\/s13059-019-1874-1 (2019).","journal-title":"Genome Biol."},{"key":"38038_CR46","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048 (2021).","journal-title":"Cell"},{"key":"38038_CR47","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031 (2019).","journal-title":"Cell"},{"key":"38038_CR48","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"38038_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273. https:\/\/doi.org\/10.1038\/ng1180 (2003).","journal-title":"Nat. Genet."},{"key":"38038_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015).","journal-title":"Cell Syst."},{"key":"38038_CR51","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740. https:\/\/doi.org\/10.1093\/bioinformatics\/btr260 (2011).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38038-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38038-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38038-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:39:08Z","timestamp":1781631548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38038-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38038"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38038-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7563"}}